We are live on ! Find out more
SLS icon

SELLAS Life Sciences
SLS

11 hedge funds and large institutions have $1.67M invested in SELLAS Life Sciences in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

7.87% more ownership

Funds ownership: 0.12% → 7.99% (+7.9%)

5% more capital invested

Capital invested by funds: $1.6M → $1.67M (+$74K)

39% less funds holding

Funds holding: 18 → 11 (-7)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
11
Holders Change
-7
Holders Change %
-38.89%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
12
Calls
$269K
Puts
–
Net Calls
+$269K
Net Calls Change
+$261K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$529K
2
OAM
Oxford Asset Management
United Kingdom
+$222K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$153K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$64.1K
5
WG
Winton Group
United Kingdom
+$59.5K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$400K
2
Renaissance Technologies
Renaissance Technologies
New York
-$17K
3
UBS Group
UBS Group
Switzerland
-$15K
4
Jane Street
Jane Street
New York
-$10K
5
MML Investors Services
MML Investors Services
Massachusetts
-$8K

SLS Hedge Fund Activity: Q4 2019 in Review

11 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q4 2019, worth a combined $1.67M — up 4.6% from $1.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of SLS and 5 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was BlackRock, adding an estimated $529K. The largest seller was 683 Capital Management, exiting entirely with an estimated $400K sold.

  • 11 institutional investors held SELLAS Life Sciences (SLS) as of Q4 2019, down from 18 in Q3 2019.
  • Funds reported $1.67M of SELLAS Life Sciences stock for Q4 2019, up 4.6% quarter-over-quarter.
  • 5 funds opened new SELLAS Life Sciences positions in Q4 2019 and 12 closed out, a net change of -7 holders.
  • The largest SELLAS Life Sciences buyer in Q4 2019 was BlackRock, an estimated $529K added.
  • The largest SELLAS Life Sciences seller in Q4 2019 was 683 Capital Management, an estimated $400K sold.

Based on aggregated 13F filings for Q4 2019.